Cellectar Biosciences, Inc. (CLRB) Free cash flow 2016–2025
Cellectar Biosciences, Inc. (CLRB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$23.1MFY2025 · since FY2016: -$8.4M → -$23.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.1M | +51.5% |
| FY2024 | -$47.7M | -43.5% |
| FY2023 | -$33.2M | -30.6% |
| FY2022 | -$25.4M | -12.1% |
| FY2021 | -$22.7M | -62.3% |
| FY2020 | -$14.0M | -19.4% |
| FY2019 | -$11.7M | +0.9% |
| FY2018 | -$11.8M | -4.0% |
| FY2017 | -$11.4M | -36.1% |
| FY2016 | -$8.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice